INKT icon

MiNK Therapeutics
INKT

Overview Fund Trends Analyst Outlook Journalist POV

21 hedge funds and large institutions have $5.96M invested in MiNK Therapeutics in 2021 Q4 according to their latest regulatory filings, with 21 funds opening new positions, increasing their positions, reducing their positions, and closing their positions.

New
Increased
Maintained
Reduced
Closed

more ownership

Funds ownership: →

Holders
21
Holders Change
Holders Change %
% of All Funds
Holding in Top 10
–
Holding in Top 10 Change
Holding in Top 10 Change %
% of All Funds
New
Increased
Reduced
Closed
Calls
–
Puts
–
Net Calls
Net Calls Change

Top Buyers

1
+$1.86M
2
+$1.54M
3
+$1.29M
4
Millennium Management
Millennium Management
New York
+$306K
5
GTCM
Gyon Technologies Capital Management
New Jersey
+$189K

Top Sellers

No sellers this quarter
Name Holding Trade Value Shares
Change 		Change in
Stake
1
$1.86M
2
$1.54M
3
$1.29M
4
$306K
5
$189K
6
$189K
7
$157K
8
$105K
9
$94K
10
$53K
11
$48K
12
$46K
13
$36K
14
$18K
15
$8K
16
$8K
17
$5K
18
$5K
19
$4K
20
$2K
21
$1K